Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Payables (2022 - 2025)

Jin Medical International's Payables history spans 4 years, with the latest figure at $22.1 million for Q3 2025.

  • For Q3 2025, Payables rose 94.2% year-over-year to $22.1 million; the TTM value through Sep 2025 reached $22.1 million, up 94.2%, while the annual FY2025 figure was $22.1 million, 94.2% up from the prior year.
  • Payables for Q3 2025 was $22.1 million at Jin Medical International, up from $11.4 million in the prior quarter.
  • Across five years, Payables topped out at $22.1 million in Q3 2025 and bottomed at $393760.0 in Q3 2022.
  • The 4-year median for Payables is $9.4 million (2023), against an average of $10.3 million.
  • The largest annual shift saw Payables soared 1805.75% in 2023 before it soared 51.61% in 2024.
  • A 4-year view of Payables shows it stood at $393760.0 in 2022, then skyrocketed by 1805.75% to $7.5 million in 2023, then soared by 51.61% to $11.4 million in 2024, then skyrocketed by 94.2% to $22.1 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Payables are $22.1 million (Q3 2025), $11.4 million (Q3 2024), and $7.5 million (Q3 2023).